Royal Bank of Canada Increases Holdings in Amedisys Inc (AMED)

Royal Bank of Canada boosted its holdings in shares of Amedisys Inc (NASDAQ:AMED) by 1,320.7% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 6,237 shares of the health services provider’s stock after acquiring an additional 5,798 shares during the quarter. Royal Bank of Canada’s holdings in Amedisys were worth $392,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Federated Investors Inc. PA boosted its position in Amedisys by 2.3% during the 2nd quarter. Federated Investors Inc. PA now owns 1,929 shares of the health services provider’s stock worth $122,000 after acquiring an additional 44 shares during the period. State Board of Administration of Florida Retirement System boosted its position in Amedisys by 0.5% during the 2nd quarter. State Board of Administration of Florida Retirement System now owns 19,658 shares of the health services provider’s stock worth $1,235,000 after acquiring an additional 93 shares during the period. Municipal Employees Retirement System of Michigan boosted its position in Amedisys by 3.5% during the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 6,590 shares of the health services provider’s stock worth $414,000 after acquiring an additional 220 shares during the period. Suntrust Banks Inc. boosted its position in Amedisys by 4.3% during the 2nd quarter. Suntrust Banks Inc. now owns 5,702 shares of the health services provider’s stock worth $358,000 after acquiring an additional 237 shares during the period. Finally, Texas Permanent School Fund lifted its holdings in shares of Amedisys by 1.2% during the 2nd quarter. Texas Permanent School Fund now owns 20,439 shares of the health services provider’s stock valued at $1,284,000 after buying an additional 243 shares during the last quarter. Hedge funds and other institutional investors own 94.62% of the company’s stock.

Shares of Amedisys Inc (NASDAQ:AMED) opened at $56.22 on Thursday. Amedisys Inc has a 1-year low of $38.00 and a 1-year high of $65.91. The company has a quick ratio of 1.33, a current ratio of 1.33 and a debt-to-equity ratio of 0.16. The firm has a market capitalization of $1,948.31, a P/E ratio of 27.47, a P/E/G ratio of 1.39 and a beta of 0.68.

Amedisys (NASDAQ:AMED) last posted its earnings results on Tuesday, November 7th. The health services provider reported $0.56 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.54 by $0.02. Amedisys had a return on equity of 14.68% and a net margin of 2.88%. The firm had revenue of $380.20 million during the quarter, compared to analyst estimates of $384.59 million. During the same period in the previous year, the company earned $0.36 EPS. The company’s revenue for the quarter was up 5.1% on a year-over-year basis. analysts predict that Amedisys Inc will post 2.23 earnings per share for the current year.

Several brokerages have recently issued reports on AMED. SunTrust Banks, Inc. reiterated a “buy” rating and set a $70.00 price target on shares of Amedisys in a report on Friday, November 10th. Robert W. Baird lifted their price target on Amedisys from $50.00 to $60.00 and gave the company a “neutral” rating in a report on Friday, November 10th. Craig Hallum reiterated a “buy” rating and set a $68.00 price target (up from $55.00) on shares of Amedisys in a report on Thursday, November 9th. Royal Bank Of Canada reiterated a “sector perform” rating and set a $62.00 price target (up from $56.00) on shares of Amedisys in a report on Thursday, November 9th. Finally, Benchmark Co. reiterated a “hold” rating on shares of Amedisys in a report on Thursday, November 9th. Six equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $61.00.

TRADEMARK VIOLATION WARNING: “Royal Bank of Canada Increases Holdings in Amedisys Inc (AMED)” was first published by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this article on another domain, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The correct version of this article can be read at https://stocknewstimes.com/2017/11/16/royal-bank-of-canada-increases-holdings-in-amedisys-inc-amed.html.

About Amedisys

Amedisys, Inc is a healthcare services company. The Company’s segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. As of December 31, 2016, the Company owned and operated 327 Medicare-certified home healthcare centers, 79 Medicare-certified hospice care centers and 14 personal-care care centers in 34 states within the United States and the District of Columbia.

Institutional Ownership by Quarter for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply